Cargando…
Exosome-mediated stable epigenetic repression of HIV-1
Human Immunodeficiency Virus (HIV-1) produces a persistent latent infection. Control of HIV-1 using combination antiretroviral therapy (cART) comes at the cost of life-shortening side effects and development of drug-resistant HIV-1. An ideal and safer therapy should be deliverable in vivo and target...
Autores principales: | Shrivastava, Surya, Ray, Roslyn M., Holguin, Leo, Echavarria, Lilliana, Grepo, Nicole, Scott, Tristan A., Burnett, John, Morris, Kevin V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452652/ https://www.ncbi.nlm.nih.gov/pubmed/34545097 http://dx.doi.org/10.1038/s41467-021-25839-2 |
Ejemplares similares
-
Stable Transcriptional Repression and Parasitism of HIV-1
por: Shrivastava, Surya, et al.
Publicado: (2018) -
Commentary on “Exosome-mediated stable epigenetic repression of HIV-1”
por: Ayariga, Joseph A., et al.
Publicado: (2022) -
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2
por: Scott, Tristan A., et al.
Publicado: (2022) -
Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator
por: Villamizar, Olga, et al.
Publicado: (2021) -
Novel Humanized Peripheral Blood Mononuclear Cell Mouse Model with Delayed Onset of Graft-versus-Host Disease for Preclinical HIV Research
por: Holguin, Leo, et al.
Publicado: (2022)